Document Detail


Evolution of two modes of intrinsic RNA polymerase transcript cleavage.
MedLine Citation:
PMID:  21454497     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
During gene transcription, the RNA polymerase (Pol) active center can catalyze RNA cleavage. This intrinsic cleavage activity is strong for Pol I and Pol III but very weak for Pol II. The reason for this difference is unclear because the active centers of the polymerases are virtually identical. Here we show that Pol II gains strong cleavage activity when the C-terminal zinc ribbon domain (C-ribbon) of subunit Rpb9 is replaced by its counterpart from the Pol III subunit C11. X-ray analysis shows that the C-ribbon has detached from its site on the Pol II surface and is mobile. Mutagenesis indicates that the C-ribbon transiently inserts into the Pol II pore to complement the active center. This mechanism is also used by transcription factor IIS, a factor that can bind Pol II and induce strong RNA cleavage. Together with published data, our results indicate that Pol I and Pol III contain catalytic C-ribbons that complement the active center, whereas Pol II contains a non-catalytic C-ribbon that is immobilized on the enzyme surface. Evolution of the Pol II system may have rendered mRNA transcript cleavage controllable by the dissociable factor transcription factor IIS to enable promoter-proximal gene regulation and elaborate 3'-processing and transcription termination.
Authors:
Wenjie Ruan; Elisabeth Lehmann; Michael Thomm; Dirk Kostrewa; Patrick Cramer
Related Documents :
21454057 - Expression of c-kit, p-erk and cyclin d1 in malignant melanoma: an immunohistochemical ...
21225257 - Direct repression of the human irf-3 promoter by e2f1.
2725947 - C-fos mrna induction under vitamin b6 antagonist-induced seizure.
8507557 - Two proto-oncogenes that play dual roles in embryonal cell growth and differentiation.
23119107 - The protection of acetylcholinesterase inhibitor on β-amyloid-induced the injury of ne...
20385107 - Ferritin h induction by histone deacetylase inhibitors.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-03-23
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  286     ISSN:  1083-351X     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-05-23     Completed Date:  2011-07-28     Revised Date:  2013-06-30    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  18701-7     Citation Subset:  IM    
Affiliation:
Gene Center and Department of Biochemistry, Center for Integrated Protein Science Munich, Ludwig-Maximilians-Universität München, Feodor-Lynen-Strasse 25, 81377 Munich, Germany.
Data Bank Information
Bank Name/Acc. No.:
PDB/3QT1
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Catalytic Domain
Crystallography, X-Ray
Evolution, Molecular*
Models, Molecular*
Protein Structure, Tertiary
RNA Polymerase I / chemistry*,  metabolism
RNA Polymerase II / chemistry*,  metabolism
RNA, Fungal / biosynthesis,  chemistry*
RNA, Messenger / biosynthesis,  chemistry*
Saccharomyces cerevisiae / enzymology*
Saccharomyces cerevisiae Proteins / chemistry*,  metabolism
Chemical
Reg. No./Substance:
0/RNA, Fungal; 0/RNA, Messenger; 0/Saccharomyces cerevisiae Proteins; EC 2.7.7.-/RNA Polymerase I; EC 2.7.7.-/RNA Polymerase II; EC 2.7.7.-/Rpb9 protein, S cerevisiae
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization.
Next Document:  Structural study of the complex stereoselectivity of human butyrylcholinesterase for the neurotoxic ...